AU8382998A - P53 influenced gene expression - Google Patents

P53 influenced gene expression

Info

Publication number
AU8382998A
AU8382998A AU83829/98A AU8382998A AU8382998A AU 8382998 A AU8382998 A AU 8382998A AU 83829/98 A AU83829/98 A AU 83829/98A AU 8382998 A AU8382998 A AU 8382998A AU 8382998 A AU8382998 A AU 8382998A
Authority
AU
Australia
Prior art keywords
gene expression
influenced gene
influenced
expression
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU83829/98A
Other languages
English (en)
Inventor
Gary A Beaudry
Arthur H. Bertelsen
Elizabeth A. Galella
Stephen L. Madden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU8382998A publication Critical patent/AU8382998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU83829/98A 1997-07-02 1998-07-02 P53 influenced gene expression Abandoned AU8382998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5157397P 1997-07-02 1997-07-02
US60051573 1997-07-02
PCT/US1998/013903 WO1999001581A1 (fr) 1997-07-02 1998-07-02 Expression genetique influencee par p53

Publications (1)

Publication Number Publication Date
AU8382998A true AU8382998A (en) 1999-01-25

Family

ID=21972132

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83829/98A Abandoned AU8382998A (en) 1997-07-02 1998-07-02 P53 influenced gene expression

Country Status (2)

Country Link
AU (1) AU8382998A (fr)
WO (1) WO1999001581A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
WO2001013105A1 (fr) 1999-07-30 2001-02-22 Agy Therapeutics, Inc. Techniques facilitant l'identification de genes candidats
KR100375183B1 (ko) * 1999-09-21 2003-03-08 주식회사 삼양제넥스 사이클린 ｇ 또는 그것의 유전자를 이용한 자궁근종 진단방법 및 진단 키트
WO2001020998A1 (fr) * 1999-09-24 2001-03-29 Linden Technologies, Inc. Identification de medicaments au moyen d'un profilage de l'expression genique
WO2001051664A2 (fr) * 2000-01-12 2001-07-19 Dana-Farber Cancer Institute, Inc. Procede de detection et de caracterisation d'un neoplasme
US6703204B1 (en) 2000-07-28 2004-03-09 The Brigham & Women's Hospital, Inc. Prognostic classification of breast cancer through determination of nucleic acid sequence expression
WO2002010436A2 (fr) * 2000-07-28 2002-02-07 The Brigham And Women's Hospital, Inc. Classification de pronostics de cancer du sein
AU2002312241A1 (en) * 2001-06-05 2002-12-16 Exelixis, Inc. B3galts as modifiers of the p53 pathway and methods of use
WO2003082078A2 (fr) * 2002-03-28 2003-10-09 Medical College Of Ohio Procede et compositions pour le diagnostic et le traitement du cancer bronchopulmonaire 'non a petites cellules' au moyen de profiles d'expression genique
US8765368B2 (en) 2007-09-17 2014-07-01 The University Of Toledo Cancer risk biomarker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000512494A (ja) * 1996-05-29 2000-09-26 ジェンザイム・コーポレーション 細胞増殖調節遺伝子

Also Published As

Publication number Publication date
WO1999001581A1 (fr) 1999-01-14

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU5272198A (en) EMP-charge-eliminator
AU8382998A (en) P53 influenced gene expression
AU6998698A (en) Dioxacycloalkan-8-one
AU4117497A (en) Micropolarimeter
AU6417799A (en) Matrix-remodeling genes
AU6185898A (en) Clavaspirins
AU6659998A (en) Tazarotene-induced gene 3 (tig3)
AU7761998A (en) Korrosionsschutzanstrichstoff
AU6525998A (en) Improved metallo-endopeptidases
AU8214598A (en) 3-benzylpiperidine
AUPP058797A0 (en) Novel gene
AU9183798A (en) Catamaran - bicycle - kayak
AU8991998A (en) Renovative pipeliner
AU4469997A (en) Heregulin-gamma
AU5391798A (en) Thiamacrolides
AU5540298A (en) Rockbolts
AU2003204513A1 (en) Gene
AU6976998A (en) Dna fragmentation factor
AU6507298A (en) Renovative pipeliner

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase